The global balloon inflation devices market size is estimated to reach USD 1059.2 million by 2033, expanding at a CAGR of 6.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing prevalence of Cardiovascular Diseases (CVDs), adoption of advanced technologies in the healthcare system, growing minimally invasive procedures, and rising geriatric population are the key factors for industry growth. In addition, the growing geriatric population is likely to develop coronary artery diseases, which propels balloon inflation devices as they are key in performing interventional cardiology operations. The increasing prevalence of CVDs across regions is anticipated to propel the market growth.
The conditions, such as peripheral, coronary, and valvular heart diseases, are the key components of CVDs aiding the need for inflation devices. The following conditions require invasive surgical treatments, such as angioplasty and stent placements, which promote the use of balloon inflation products. According to the American College of Cardiology Foundation, an estimated 1.2 million angioplasties are performed in the U.S. each year. The global market was disrupted during the COVID-19 pandemic in 2020 which affected the manufacturing and transportation of these devices. Furthermore, elective procedures were delayed or canceled, which hampered the market growth.
Healthcare facilities prioritized COVID-19 patients, leading to a decrease in the number of interventional procedures performed. According to American Heart Association, Inc., a 49% fall was noticed in percutaneous coronary intervention (PCI) in the UK after March 2020. A change in the federal reimbursement scenario in the U.S. is expected to have a positive impact on balloon inflation devices. Medicare announced to cover several types of PCI interventions as an outpatient service in the U.S. Moreover, the Centers for Medicare & Medicaid Services (CMS) estimated that 5% of the cost can be saved by shifting coronary interventions to ambulatory surgical centers (ASCs) from hospitals.
Request a free sample copy or view report summary: Balloon Inflation Devices Market Report
The analog display segment accounted for the largest revenue share at 62.3% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period. This growth is due to its established role in cardiovascular and peripheral interventions, simple pressure monitoring, easy operation, and wide availability in healthcare facilities.
The interventional cardiology segment led the market with 41.3% revenue share in 2025, driven by the increasing use of balloon angioplasty and other catheter-based heart procedures, a higher rate of coronary artery disease, and a shift toward minimally invasive treatments.
The hospitals & clinics segment accounted for the largest revenue share, at 79.8% in 2025, driven by the high volume of cardiovascular, peripheral vascular, urological, and other catheter-based procedures performed in these settings.
Grand View Research has segmented the global balloon inflation devices market on the basis of display type, application, end use, and region
Balloon Inflation Devices Display Type Outlook (Revenue, USD Million, 2021 - 2033)
Analog Display
Digital Display
Balloon Inflation Devices Application Outlook (Revenue, USD Million, 2021 - 2033)
Interventional Cardiology
Interventional Radiology
Peripheral Vascular Procedures
Gastroenterology Procedures
Urology Procedures
Others
Balloon Inflation Devices End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals & Clinics
Ambulatory Surgical Centers
Balloon Inflation Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Balloon Inflation Devices Market
Merit Medical Systems
Boston Scientific Corporation
Medtronic
CONMED Corporation
BD
B. Braun Medical Inc.
Nordson Corporation
Cook
TZ Medical, Inc.
US Endovascular, LLC
"The quality of research they have done for us has been excellent..."